MedPath

Otologic Pharmaceutics, Inc.

Otologic Pharmaceutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://otologicpharma.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC

Phase 1
Completed
Conditions
Hearing Loss
Sensorineural Hearing Loss
Noise-Induced Hearing Loss
Interventions
First Posted Date
2014-10-08
Last Posted Date
2015-05-01
Lead Sponsor
Otologic Pharmaceutics, Inc.
Target Recruit Count
32
Registration Number
NCT02259595
Locations
🇺🇸

Wake Research Associates, Raleigh, North Carolina, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.